Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
11.02
-0.37 (-3.25%)
At close: Oct 6, 2025, 4:00 PM EDT
10.90
-0.12 (-1.09%)
After-hours: Oct 6, 2025, 7:43 PM EDT
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
$323,375
Profits / Employee
-$110,425
Market Cap
979.42M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 713 | 37 | 5.47% |
| Dec 31, 2023 | 676 | -43 | -5.98% |
| Dec 31, 2022 | 719 | -43 | -5.64% |
| Dec 31, 2021 | 762 | 262 | 52.40% |
| Dec 31, 2020 | 500 | -21 | -4.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VALN News
- 11 hours ago - Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business Updates - GlobeNewsWire
- 6 days ago - Valneva Reports 95% Seroresponse Four Years After Single Shot of Chikungunya Vaccine IXCHIQ® - GlobeNewsWire
- 4 weeks ago - Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate - GlobeNewsWire
- 6 weeks ago - Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday - Benzinga
- 6 weeks ago - Johnson Fistel Investigates Valneva Following FDA Suspension - GlobeNewsWire
- 6 weeks ago - Safety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In US - Benzinga
- 6 weeks ago - FDA suspends Valneva's chikungunya vaccine license in the U.S. - Reuters
- 6 weeks ago - Valneva Announces FDA's Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S. - GlobeNewsWire